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Abstract During August and September of 2013,
temperature data loggers were shipped to and from an
AATB accredited and FDA registered allograft tissue
processing facility in Belgrade, MT (Bacterin Inter-
national, Inc.) to five warm climate cities (Dallas, TX,
El Paso, TX, New Orleans, LA, Phoenix, AZ, and
Tampa, FL). Shipping data acquired from 72 inde-
pendent shipments were analyzed to generate an
assessment of temperature exposure, shipment times,
and shipping event durations experienced during
routine distribution. Overall the packages experienced
an average temperature of 26.2 ± 2.3 C which
mirrored the average external ambient temperature
of 25.8 ± 3.0 C. However, temperature spikes above
40 C were frequently observed. The data from the
model shipments were extrapolated to provide a
worst-case high temperature spike of 52.9 C for
12 h and 14 min. Multiple lots of a commercially
available demineralized bone matrix (DBM) putty
(OsteoSelect DBM Putty) were subjected to contin-
uous heating at 50 C, to multiple worst-case temper-
ature spikes, and to multiple freeze–thaw cycles to
assess the effects of these temperature extremes on the
handling and osteoinductivity of the allograft tissue.
Five weeks of continuous exposure to 50 C and 12
simulated worst-case one-way shipments did not
adversely affect the handling characteristics or the
in vivo osteoinductivity of the product.
Keywords Shipping validation  Demineralized
bone matrix  Allograft tissue  Osteoinductivity 
Temperature effects
Introduction
The United States Centers for Disease Control and
Prevention (CDC) estimates more than one million
allografts are implanted annually in the United States
(CDC Transplant Safety Overview 2015). Many of
these allografts are stored and distributed at ambient
temperature, including amniotic tissue, dermis, struc-
tural bone grafts, and demineralized bone matrix
(DBM) products. Regardless of tissue type, all allo-
grafts are transported in some manner to the surgical
facilities in which they are implanted. As it has been
previously reported that packages can be exposed to
extreme temperatures during routine shipment (Taylor
2001), it is incumbent on allograft processors to
determine the effects of such transportation on the
integrity of the allografts they distribute.
Because both low and high temperature extremes
may be detrimental to allograft performance, federal
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regulations state that facilities must ‘‘establish appro-
priate shipping conditions to be maintained during
transit’’ (21 CFR Part 1271 2004). Accordingly, the
U.S. Food and Drug Administration (FDA) and the
American Association of Tissue Banks (AATB)
require manufacturers to establish acceptable temper-
ature limits for storage of products and to perform on-
going storage monitoring. While monitoring of these
conditions is easily performed on-site, environmental
monitoring during distribution is more challenging.
Various solutions exist for temperature-controlled
shipments (Ohkawara et al. 2012; Qin et al. 2013)
but these options are not always physically or
economically practical (Elliott and Halbert 2005;
Singh et al. 2008).
Exposure to extremes in temperature has been
shown to affect the mechanical and biological perfor-
mance of a variety of human allograft tissues (Han
et al. 2005; Shimp 2008). One commonly distributed
form of allograft tissue particularly susceptible to
thermal extremes is DBM (Russell and Block 1999;
Urist 1965). The biologic activity, and by extension
the clinical performance, of DBM is governed pri-
marily by the protein growth factors associated with
the bone collagen. The stability of bone protein growth
factors has been reported to be negatively affected by
prolonged exposure to temperatures above 45 C.
Additionally, the literature suggests that ‘‘wet’’ or
hydrated DBM is more susceptible to thermal degra-
dation than DBM in a lyophilized form (Shimp 2008).
The heat stability of hydrated allografts throughout
shipping warrants investigation since many commer-
cially available DBM allografts are provided in a
hydrated state due to the addition of carrier materials.
While previous studies have examined the effects
of simulated transit conditions on protein formulations
(Telikepalli et al. 2015), insulin samples (Chandler
et al. 2008), essential drugs (Hogerzeil et al. 1992),
and blood (Hankinson et al. 1989), a comprehensive
evaluation of DBM stability during shipment has yet
to be reported.
In this study, we sought to determine the temper-
ature extremes allograft tissue may encounter during
routine shipping conditions. We then tested the effects
of such temperature exposure on both the physical
characteristics and in vivo osteoinductivity of OsteoS-
elect, a commercially available DBM putty. In order
to assess the impact of elevated temperature on the
DBM, a relevant industry adopted and FDA accepted
in vivo cGMP lot release assay was used to evaluate
the osteoinductive potential of the test article.
Materials and methods
Shipping conditions determination
In August and September of 2013, calibrated temper-
ature loggers (SenseAwareSM 1000, FedEx and Ham-
ster-E EHT1, ELPRO) were shipped by air from
Bacterin’s tissue processing facility in Belgrade,
Montana to the warm climate cities of Dallas, TX,
El Paso, TX, New Orleans, LA, Phoenix, AZ, and
Tampa, FL. The temperature loggers were packaged
and shipped in a manner representative of routine
distribution of Bacterin’s allograft tissues. The pack-
ages containing the temperature loggers were received
and then shipped back to the tissue processing facility
in an identical manner as the outgoing shipments. The
packages were shipped via a combination of over-
night, 2-day, and weekend delivery (up to 4 days in
transit) to account for a variety of shipping methods
and potential delays in shorter-duration shipments.
Multiple courier services were employed (FedEx,
UPS, and USPS) to account for potential differ-
ences between major shipping providers.
Once returned to Bacterin, the temperature data
were compared to the reported ambient temperature for
the city delivered to and against tracking information
for the location of the package (inside jet, at sort
facility, etc.). The data were analyzed to determine the
impact of independent, external shipping factors on the
internal package temperature. Specific shipping factors
investigated included courier choice, duration of
shipping events, and concurrent external temperatures.
Data from each shipment were compiled to gener-
ate a temperature exposure profile representative of
routine distribution (Fig. 1). As the data demonstrated
temperature spikes in excess of 40 C, a plot was then
generated to correlate average ambient temperature to
these temperature spikes. For each individual ship-
ment, the daily high temperature of the destination city
was plotted against the maximum temperature the
packages experienced during transit. Furthermore, to
determine the worst-case temperature that could be
expected during shipment, these data were extrapo-
lated to include historical highs from the five cities
(Fig. 2). This extrapolated temperature extreme was
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used for the subsequent allograft stability studies
reported herein.
Effects of worst-case shipping temperatures
on a commercially available DBM putty
DBM putty
OsteoSelect DBM putty (Bacterin International,
Inc.) was used for all testing detailed herein. OsteoS-
elect DBM Putty is a malleable bone grafting material
comprising demineralized bone matrix (DBM) allo-
graft (74 % by dry mass) suspended in a hydrated
carboxymethyl cellulose (CMC) carrier (26 % by dry
mass). The product is packaged in a polystyrene jar
sealed within a high moisture barrier foil pouch and
sterilized using a validated 9 kGy minimum gamma
irradiation dose on dry ice to limit irradiation induced
damage to the growth factors present within the graft.
The product has been commercially available since
2009 and indicated for use as bone void filler and bone
graft substitute in the extremities, pelvis, and postero-
lateral spine.
Prolonged heating All allograft tissue utilized
during the course of this study had confirmed
research consent. The OsteoSelect DBM putty
samples were exposed to continuous heating at
50 C for 0, 1, 2, 3, 4, and 5 weeks in their final
packaging to evaluate the effects of prolonged
temperature elevation on allograft performance. The
sample set comprised three different lots of
OsteoSelect at each time point examined (a total of
54 grafts employed in this testing). For each time
point, the osteoinductivity (OI) (n = 1 per lot) of the
grafts was evaluated in a standard ectopic implantation
assay in athymic rats (Edwards et al. 1998). This assay
scores the histological evidence for new bone
formation following 28 days of implantation and is a
standard lot release assay for OsteoSelect DBM putty,
(see additional detail below). The OI scores for the
heated samples were compared to the OI scores of
unheated, control samples using a paired, two-tailed
t test. Additionally, for each time point the handling
characteristics of the heated grafts (n = 2 per lot) were
compared to non-heated control grafts from the same
lot by three blinded evaluators to ensure the functional
utility of the graft had not been altered as a result of the
prolonged heating.
Temperature spike cycling Following the
completion of the prolonged heating experiments,
additional DBM putty samples were exposed to
temperature cycling to evaluate the effect of extreme
temperature spikes, which may be encountered during
routine distribution, on the performance of the
allografts. To account for both hot and cold
temperature spikes, DBM putty samples were
exposed to either high-temperature cycles (52.9 C
for 12 h and 14 min, 23 C for 12 h) or freeze–thaw
cycles (-20 C for 12 h, 23 C for 12 h). The high-
temperature and freeze–thaw cycles were selected to
represent extreme temperature exposure for a one-way
shipment. Multiple cycles were evaluated to account
for the possibility of tissue returns and redistribution,
which is common in the industry.
The testing comprised three different lots of
recently processed DBM putty. Two samples from
each lot were exposed to either: (a) no exposure
(control samples), (b) seven high-temperature cycles,
or (c) seven freeze–thaw cycles. For each condition
examined, the osteoinductivity (OI) (n = 1 per lot)
and handling characteristics (n = 1 per lot) of the
grafts were evaluated in an identical manner as
described for the continuous 50 C heating sample
set. A total of 18 grafts were employed for this testing.
Following the initial testing of recently processed
DBM putty, follow-up testing was performed on three
lots of 3-year old DBM putty to assess the effects of
temperature exposure at the validated product family
shelf-life (product stability data on file at Bacterin
International, Inc.). Two samples from each lot were
exposed to either: (a) no exposure (control samples),
(b) twelve high-temperature spikes, or (c) twelve
freeze–thaw cycles. Following the temperature expo-
sure, OI testing (n = 1 per lot) and handling charac-
terization (n = 1 per lot) were also performed. Again,
a total of 18 grafts were employed for this testing.
The osteoinductivity (OI) scores were compared
between groups a, b, and c for both sets of temperature
cycling experiment samples using a paired, two-tailed
t test. Table 1 provides a summary of the various
temperature treatments and testing employed.
In vivo osteoinductivity (OI) testing in an athymic rat
model The OI testing employed an ectopic bone
formation model in accordance with current industry-
wide lot release testing standards. All OI testing was
performed at WuXi AppTec (St. Paul, Minnesota,
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USA) using a validated, IACUC approved protocol. In
brief, two implant sites per sample (250 ± 25 mg)
were implanted into a surgically created intramuscular
pouch of the biceps femoris muscles of athymic male
rats. Each animal received two implants of DBM putty
and samples were randomized so that no animal
received the same lot in both non-bony implant sites.
After 28 days, the animals were humanely euthanized
and the implants were removed.
Tissues were fixed in 10 % neutral buffered
formalin, decalcified, and processed into paraffin
blocks. Sections were cut, slide mounted, and stained
with hematoxylin and eosin (H&E stain). Final
determination of osteoinduction was based on the
semi-quantitative histopathology evaluation of multi-
ple elements of new bone formation using an adapted
version of the scoring system reported by Edwards
(Table 2; Edwards et al. 1998). All histology was
performed by an independent, board-certified veteri-
nary pathologist. If elements of new bone formation
are observed during histopathology, the test material is
considered osteoinductive. If no elements of new bone
formation are observed, the test materials are consid-
ered non-osteoinductive.
Results
Worst-case temperature exposure during shipment
Eighty-eight packages were shipped as part of the
testing to yield 72 useable one-way shipments and
over 3300 h of shipment temperature data for analysis.
Sixteen shipments were excluded due to excessive,
non-representative shipping delays or problems with
data acquisition by the temperature loggers. Details of
the shipment method and destination cities for the 72
unique shipments are provided in Table 3.
Figure 1 provides a scatter plot of the temperature
profile experienced during the 25 one-way overnight
FedEx shipments to the five warm climate cities
included in the testing. The average time points for
shipping events are labeled on the chart. For a standard
FedEx shipment, the five shipping events were
(a) picked up at Bacterin, (b) arrival at Memphis,
(c) departure from Memphis, (d) arrival at destination
city, and (e) delivery (Note: Memphis is a FedEx
shipping hub for all express packages). Average time
elapsed (hours:minutes) at shipping events b–e, were
6:20, 10:33, 12:28, and 21:48, respectively.
As shown in Fig. 1, the temperatures of the interior
of the packages were generally stable throughout
shipment, with a trend towards increasing tempera-
tures as the packages were on route for delivery in the
destination city. A simple linear regression of the
Table 1 Overview of DBM putty temperature treatments
Treatment name Description DBM putty details Testing completed (per time point
or per cycling group)
Prolonged
heating
50 C for 0–5 weeks Recently processed
Three different lots
n = 3 OI testing




One cycle = 52.9 C for 12 h and
14 min, 23 C for 12 h
Three lots of recently processed (7
total cycles)
Three lots of 3 years old DBM
putty (12 total cycles)
n = 3 OI testing
n = 3 handling evaluation
Freeze–thaw
cycling
One cycle = -20 C for 12 h, 23 C
for 12 h
Three lots of recently processed (7
total cycles)
Three lots of 3 years old DBM
putty (12 total cycles)
n = 3 OI testing
n = 3 handling evaluation
Table 2 Scoring of histologic sections (Edwards et al. 1998)
Score New bone formation
0 No new bone
1 1–25 % of explant involved in new bone formation
2 26–50 % of explant involved in new bone formation
3 51–75 % of explant involved in new bone formation
4 [75 % of explant involved in new bone formation
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package temperature versus time in the destination
city (shipping duration time points of 12:29–21:55)
provided a coefficient of determination (R2) value of
0.68.
For the 72 unique, one-way shipments analyzed, the
average internal temperature was 26.2 ± 2.3 C mir-
roring the average external ambient temperature of
25.8 ± 3.0 C. However, the packages routinely
experienced spikes in temperature above 40 C (for
an average of 48 min with a range of 0 min–12 h and
14 min). These temperature spikes invariably
occurred when the packages were on a vehicle for
delivery or being loaded onto an aircraft. The maxi-
mum package temperature observed was 49.3 C that
originated from a shipment to Phoenix on a day when
the high temperature exceeded 43 C.
The maximum package temperature was plotted
against the reported maximum ambient temperature
for all the combined 72 one-way shipments (Fig. 2).
The temperatures correlated with a R2 value of 0.62
for the linear regression line. This plot was extrapo-
lated to include the historical highest temperatures for
any of the cities examined (50 C in Phoenix on June
26, 1990). By doing so, it was determined that the
worst-case high-temperature spike a package would
ever reasonably be subjected to is 52.9 C. In order to
set an extreme temperature exposure for subsequent
testing, this high temperature was combined with the
observed maximal amount of time a package was
exposed to over 40 C (12 h and 14 min).
Concurrent shipping conditions
In order to test variability of temperature exposure of
different packages shipped concurrently, 12 sets of
paired packages were shipped as part of the 72 one-way
shipments described above. These paired shipmentswere
sent on the same shipping origination date, using the
same shipment method (overnight, 2-day or weekend),
and analyzed for differences once returned to Bacterin.
All five warm climate cities were used as shipment
destinations and originations in this sample set. For the
majority of the paired shipments, the temperature profiles
were nearly indistinguishable (average difference
0.6 ± 0.1 C). Figure 3 provides a scatter plot represen-
tation of the temperature data collected for one such
paired set of shipments mailed from Bacterin to El Paso,
TX. The data demonstrate that the most important aspect
of temperature exposure is the geographic location of the
package (in flight, on route for delivery, etc.) and not its
specific location within a transport vehicle.
Courier services comparison
The temperature conditions encountered during four
shipments to and from Tampa to Phoenix were also
collected and analyzed for the three different courier
services. All of these shipments originated on the same
dates in September 2013. Table 4 provides a side-by-
side comparison of the trip duration, maximum pack-
age temperatures and maximum ambient temperatures
during the four, one-way shipments. The package
temperatures during shipment were similar for all three
couriers, with no statistically significant differences.
Stability of a DBM putty under elevated
temperature exposure
OsteoSelect DBM Putty grafts were exposed to
continuous 50 C heating as detailed in Table 5.
Table 3 Overview of 72 unique one-way shipments to warm climate cities
Shipping method Dallas El Paso New Orleans Phoenix Tampa Totals
Overnight; outgoinga to city 6 5 3 6 8 28
Overnight; returningb from city 1 2 3 5 1 12
2-day; outgoinga to city 2 3 4 4 3 16
2-day; returningb from city 0 0 0 0 4 4
Weekendc 3 2 0 5 2 12
Totals 12 12 10 20 18 72
a All shipments outgoing to city originated from Belgrade, MT
b All shipments returning from city were sent to Belgrade, MT
c All weekend shipments were returning to Belgrade, MT from the destination, warm climate city. The weekend shipments included
Thursday for Monday delivery, Friday for Monday delivery, and Friday for Tuesday delivery


























Package A Package B
Fig. 3 Temperature profile
of two packages shipped
concurrently from Bacterin
to El Paso, TX
Table 4 Side-by-side comparison of four shipments by different couriers
Tripa Data collected Courier
FedEx UPS USPS
A Trip duration (hours:minutes) 46:23 46:34 23:05b
B 93:40 89:42 96:43
C 20:20 15:21 19:32
D 50:06 51:42 47:06
A Maximum ambient temperature (C) 35.6 37.2 40.6
B 36.7 36.7 36.7
C 26.0 25.0 26.0
D 26.0 26.7 26.0
A Maximum package temperature (C) 38.8 47.9 29.7
B 40.8 42.5 30.6
C 27.9 27.8 24.6
D 32.4 27.8 26.5
a Trip A, 2-day shipment to Phoenix, AZ from Belgrade, MT; Trip B, Friday for Tuesday to Belgrade, MT from Phoenix, AZ; Trip
C, Overnight shipment to Tampa, FL from Belgrade, MT; Trip D, 2-day shipment to Belgrade, MT from Tampa, FL
b The USPS shipment to Phoenix, AZ from Belgrade, MT arrived a day ahead of schedule
Table 5 Osteoinductivity
results of DBM putty
continuous 50 C heating
a Results from three
separate lots
Duration of temperature treatment OI resultsa
1 week/168 h at 50 C 100 % of controls (p = 1.00)
2 weeks/336 h at 50 C 125 % of controls (p = 0.52)
3 weeks/504 h at 50 C 100 % of controls (p = 1.00)
4 weeks/672 h at 50 C 75 % of controls (p = 0.43)
5 weeks/840 h at 50 C 75 % of controls (p = 0.43)
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Following temperature exposure, the handling char-
acteristics of the grafts were evaluated by three
blinded technicians and the osteoinductive potential
of the grafts was evaluated using the standard in vivo
lot release assay for the product family. The testing
revealed that exposure to 50 C had no effect on the
handling characteristics of the grafts for all treatment
groups (168–840 h). Additionally, all grafts main-
tained similar levels of osteoinductivity (no statistical
differences) compared to control grafts from the same
lots.
Stability of a DBM putty exposed to worst-case
shipping temperatures
To evaluate the effect of the worst-case shipping
conditions identified above on the DBM, recently
processed grafts were exposed to seven high-temper-
ature cycles and seven freeze–thaw cycles. Further-
more, to ensure the potential temperature exposure did
not affect the established shelf life of the product,
3 year old grafts were exposed to twelve high-
temperature cycles and twelve freeze–thaw cycles.
The testing details and results are reported in Table 6.
Representative plots of the temperature profile for
twelve high-temperature cycles and twelve-free–thaw
cycles are provided in Figs. 4 and 5, respectively.
None of the temperature treatments detectably
affected the handling characteristics for any of the
lots examined. All grafts received passing OI test
results defined by histological evidence of new bone
formation in the ectopic implant sites. The tempera-
ture exposure did not statistically affect the OI scores
for any of the conditions or lots examined (all
p[ 0.05).
Four representative histology images of the in vivo
bone formation at 28 days post-implantation of the
temperature cycled DBM putty for three separate
implant sites are provided in Fig. 6. The DBM putty
implants are pictured rimmed with cells and new bone
formation. The images shown in Fig. 6a, b are of the
same implant site and differing magnifications. As
shown in the enlarged image of Fig. 6b, there is a
seamless transition between the residual implant
material and newly formed bone. The remaining
images, Fig. 6c, d illustrate new bone formation at two
different implant sites.
Discussion
Throughout the world, DBM allografts are widely
employed in orthopedic surgery as bone graft substi-
tutes and extenders (Drosos et al. 2015; Gruskin et al.
2012; Tilkeridis et al. 2014). While stability studies
are routinely performed to ensure the grafts maintain
their functional performance over the shelf-life of the
product, the impact of extreme environmental expo-
sure during distribution has received far less attention.
The data presented herein demonstrate that even under
express shipping conditions, allograft tissue may be
exposed to temperatures in excess of 50 C. As this is
outside of the recommended storage conditions for
most allograft tissues, it is of the upmost importance to
test the effect of this potential temperature exposure on
the biological performance of DBM allografts. This is
especially important for allografts distributed in a
hydrated state where free water can catalyze degrada-
tion of the proteinaceous growth factors present within
the grafts (Shimp 2008). In this study, a thorough
shipping validation was carried out on OsteoSelect
DBM putty to ensure consistency of the product’s
osteoinductive potential regardless of distribution
conditions.
The osteoinductive potential of DBM upon implan-
tation into a heterotopic site of a living animal was first
described by Urist (1965). Later, a semi-quantitative
measure was suggested by Edwards in order to provide
a reproducible test method for the evaluation of the
osteoinductive potential of DBM in a rat model
(Edwards et al. 1998). Since then, variations of this
in vivo assay have been widely adopted in the tissue
banking industry for research evaluation, cGMP lot
release testing, product stability testing, and regula-
tory submission of DBM containing medical devices
featuring a claim of osteoinductive potential. In 2013,
Table 6 Results of DBM putty temperature cycling
Temperature treatment OI results
Recently processed DBM putty lotsa
7 Heat cycles 100 % of controls (p = 1.00)
7 Freeze–thaw cycles 117 % of controls (p = 0.43)
3 year old DBM putty lotsa
12 Heat cycles 80 % of controls (p = 0.66)
12 Freeze–thaw cycles 80 % of controls (p = 0.66)
a Results from three separate lots
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ASTM test method F2529 was published in an attempt
to further standardize this basic test of osteoinductive
potential, thus highlighting the importance of the
in vivo assay (ASTM F2529-13). However, at the time
of preparation of this manuscript, the ASTM test
method has not been largely adopted across the
allograft industry as a means of routine lot testing of
510(k) cleared DBM based products.
Out of over 3300 shipment hours, the study
demonstrated that package temperatures were most
impacted by the package’s geographic location and
not significantly affected by the courier service type or
the package’s specific location within the transport
vehicle during distribution. In general, the average
package internal temperature closely mirrored the
average external ambient temperature, and it was
noted that the maximum package temperatures had a
linear correlation with, and could be predicted from,
maximum ambient temperatures (Fig. 2). Addition-
ally, temperature spikes above 40 C were routinely
observed. Based on historical temperature data, we
extrapolated the worst-case high-temperature spike
expected to be encountered during routine distribution
in summer months (52.9 C for 12 h and 14 min).
Following the evaluation of temperature extremes,
OsteoSelect DBM putty was exposed to these worst-
case shipping conditions to ensure the exposure did
not adversely affect the biological activity of the
product. The data collected demonstrated that at least
5 weeks of continuous 50 C heat and 12 simulated
worst-case one-way shipments did not adversely affect
the osteoinductive potential or handling characteris-
tics of the grafts.
Considering the robustness of the experimental
protocol, it is somewhat unanticipated that the
OsteoSelect DBM putty grafts maintained their bio-
logical activity throughout all conditions examined. It
is known in the field that bone protein growth factors
undergo degradation and inactivation upon high
temperature exposure (Ijiri et al. 1994). Therefore, it
is instructive to compare these results to those
previously reported in the literature. In a landmark
study published in 2005, Han and colleagues evaluated
various heat exposures of DBM powder on its in vitro
and in vivo osteoinductivity. Interestingly, the paper
reported that while anhydrous DBM powder was
largely unaffected at temperature exposure up to



















Fig. 4 Temperature profile





















Fig. 5 Temperature profile
for 12 freeze–thaw cycles of
DBM putty
Cell Tissue Bank (2016) 17:677–687 685
123
lost an appreciable amount of OI when exposed to
45 C for 5 weeks and a large amount of OI when
exposed to 55 C for 5 weeks (Han et al. 2005).
One possible explanation for the contrast between
these results and those presented herein is that the
CMC carrier of the OsteoSelect DBM Putty may
function as a thermal protectant to the collagen and
growth factors that compose DBM. Alternatively, the
hygroscopic CMC carrier may serve to limit the
amount of free water available to degrade the growth
factors present in the DBM. Moreover, the intramus-
cular OI assay is likely insufficiently sensitive to
detect minor reductions in osteoinductive potential.
While it is possible that some degree of osteoinduc-
tivity was lost under the experimental conditions, we
were unable to discern any statistically significant
decrease within the sensitivity limits of the assay.
Although it is anticipated that an in vitro assay such
as ELISA may provide a more quantitative measure of
the thermal degradation of select protein growth
factors within the DBM, these assays only measure
one or a limited number of the biochemical markers
associated with the induction of bone formation. Thus,
the in vitro assays are only indirect measures of the
osteoinductive potential of a DBM. In this study, we
sought to utilize the most relevant assay model for the
assessment of a DBM to induce bone formation.
Although the in vivo model is not as quantitative as the
in vitro assays, the in vivo evaluation is still appro-
priate given its widespread use in industry as the
absolute measure of osteoinductive potential.
While we predict that further heating at tempera-
tures above 50 C will eventually inactivate the
collagen associated growth factors, such excessively
Fig. 6 In vivo bone formation at 28 days post-implantation of
OsteoSelect DBM putty in an athymic rat (H&E stain), three
implant sites a 950 magnification of implant site #1. b 9200
magnification of the black box region of implant site #1 shown
in Fig. 6a. c 950 magnification of implant site #2. d 3200
magnification of implant site #3. (CM condensed mesenchyme,
DBM residual DBM implant, NB new mature bone, OB
osteoblasts, OC osteocytes, OCL osteoclast, OD osteoid)
686 Cell Tissue Bank (2016) 17:677–687
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prolonged heating conditions would not be represen-
tative of real-world shipping conditions. Under the
challenging, simulated shipping conditions employed
in this study, this DBM putty maintained its initial
handling characteristics and in vivo osteoinductivity.
It is not known how generalizable these findings are to
other DBM products with aqueous-based carriers.
Therefore, we recommend allograft manufacturers
perform a similar analysis for their products to ensure
the integrity of their grafts is not compromised by
temperature extremes during routine distribution.
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